These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 2970783
1. Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy. Holubarsch C, Hasenfuss G, Heiss WH, Just H. Am J Cardiol; 1988 Sep 09; 62(8):104E-107E. PubMed ID: 2970783 [Abstract] [Full Text] [Related]
3. Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone. Hasenfuss G, Holubarsch C, Heiss HW, Meinertz T, Bonzel T, Wais U, Lehmann M, Just H. Circulation; 1989 Jul 09; 80(1):51-64. PubMed ID: 2525432 [Abstract] [Full Text] [Related]
4. Influence of enoximone on myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside. Hasenfuss G, Holubarsch C, Heiss HW, Meinertz T, Hofmann T, Just H. J Cardiovasc Pharmacol; 1989 Jul 09; 14 Suppl 1():S69-74. PubMed ID: 2480489 [Abstract] [Full Text] [Related]
5. Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside. Hasenfuss G, Holubarsch C, Heiss HW, Rattert B, Just H. Basic Res Cardiol; 1989 Jul 09; 84 Suppl 1():225-33. PubMed ID: 2818456 [Abstract] [Full Text] [Related]
6. Influence of UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Hasenfuss G, Holubarsch C, Heiss HW, Just H. Am Heart J; 1989 Sep 09; 118(3):512-9. PubMed ID: 2773772 [Abstract] [Full Text] [Related]
7. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone. Schröder T, Hering JP, Foth H, Ferrari M, Sipinková I, Hellige G. Arzneimittelforschung; 1994 Aug 09; 44(8):948-50. PubMed ID: 7945538 [Abstract] [Full Text] [Related]
8. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy. Heiss HW, Hasenfuss G, Holubarsch C, Meinertz T, Just H. Am J Cardiol; 1987 Aug 14; 60(5):53C-56C. PubMed ID: 2956869 [Abstract] [Full Text] [Related]
9. Hemodynamics and myocardial oxygen metabolism of pulsus alternans in patients with dilative cardiomyopathy. Hasenfuss G, Holubarsch C, Heiss HW, Bonzel T, Funfack M, Revenaugh M, Meinertz T, Just H. Clin Cardiol; 1987 May 14; 10(5):323-7. PubMed ID: 2954730 [Abstract] [Full Text] [Related]
10. Coupling between myocardial oxygen consumption and mechanics in patients with dilative cardiomyopathy. Influence of vasodilation and positive inotropism. Hasenfuss G, Holubarsch C, Heiss HW, von Herrath M, Just H. Prog Clin Biol Res; 1989 May 14; 315():613-5. PubMed ID: 2529573 [No Abstract] [Full Text] [Related]
11. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy. Baumann G, Ningel K, Permanetter B. J Cardiovasc Pharmacol; 1989 May 14; 13(5):730-8. PubMed ID: 2472521 [Abstract] [Full Text] [Related]
12. Effects of enoximone and R 80122, a new selective phosphodiesterase III inhibitor, on hemodynamics and myocardial energetics in patients with ischemic heart disease. Stephan H, Kazmaier S, Hoeft A, Sonntag H. Anesth Analg; 1994 Dec 14; 79(6):1059-65. PubMed ID: 7978427 [Abstract] [Full Text] [Related]
14. Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy. Holubarsch C, Hasenfuss G, Allgeier M, Heiss HW, Just H. Basic Res Cardiol; 1989 Dec 14; 84 Suppl 1():257-65. PubMed ID: 2530975 [Abstract] [Full Text] [Related]